AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Insmed Incorporated to Present at Two Investor Conferences in September.
ByAinvest
Thursday, Aug 21, 2025 7:37 am ET1min read
Insmed Incorporated announced that management will present at the Wells Fargo 2025 Healthcare Conference in Boston on September 5, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on September 9, 2025. The events will be webcast live and available on the company's website. Insmed Incorporated is a biopharmaceutical company focused on delivering therapies for serious diseases.
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company, has announced that its management will present at two prominent investor conferences in September. The company will participate in the Wells Fargo 2025 Healthcare Conference in Boston on Friday, September 5, 2025, at 8:00 a.m. ET, and the Morgan Stanley 23rd Annual Global Healthcare Conference in New York on Tuesday, September 9, 2025, at 4:50 p.m. ET. Both events will be webcast live and accessible via the company's investor relations section on its website [1].Insmed Incorporated is dedicated to delivering first- and best-in-class therapies to transform the lives of patients facing serious diseases. The company's portfolio includes approved and mid- to late-stage investigational medicines, as well as cutting-edge drug discovery focused on serving patient communities with the greatest need. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including two approved therapies for chronic, debilitating lung diseases [2].
The company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Insmed is headquartered in Bridgewater, New Jersey, with offices and research locations throughout the United States, Europe, and Japan [3].
Investors and media interested in attending the presentations can visit the company's investor relations section on its website for more information. The webcasts will be archived for 30 days following the conclusion of the live events.
References:
[1] https://www.prnewswire.com/news-releases/insmed-to-present-at-september-investor-conferences-302535055.html
[2] https://finance.yahoo.com/news/insmed-present-september-investor-conferences-110000193.html
[3] https://www.marketscreener.com/news/insmed-to-present-at-september-investor-conferences-ce7c51d3df88ff27
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet